Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions (2000)

  • Authors:
  • USP affiliated authors: BIANCO, ANTONIO CARLOS - ICB
  • USP Schools: ICB
  • DOI: 10.1007/bf03343719
  • Subjects: FISIOLOGIA
  • Language: Inglês
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/bf03343719 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Journal of Anatomy

    ISSN: 0021-8782

    Citescore - 2017: 2.46

    SJR - 2017: 1.078

    SNIP - 2017: 1.102


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    ICB12100015581PC-ICB BMB SEP 2000
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ARNHOLD, I. J.; OLIVEIRA, S. B.; OSORIO, M G; et al. Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions. Journal of Endocrinological Investigation[S.l.], v. 23, p. 258-262, 2000. DOI: 10.1007/bf03343719.
    • APA

      Arnhold, I. J., Oliveira, S. B., Osorio, M. G., Carrilho, A. J. F., Nicolau, W., Bianco, A. C., & Mendonça, B. B. (2000). Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions. Journal of Endocrinological Investigation, 23, 258-262. doi:10.1007/bf03343719
    • NLM

      Arnhold IJ, Oliveira SB, Osorio MG, Carrilho AJF, Nicolau W, Bianco AC, Mendonça BB. Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions. Journal of Endocrinological Investigation. 2000 ; 23 258-262.
    • Vancouver

      Arnhold IJ, Oliveira SB, Osorio MG, Carrilho AJF, Nicolau W, Bianco AC, Mendonça BB. Lack of reduction in body fat after treatment with insulin-like growth factor-I in two children with growth hormone gene deletions. Journal of Endocrinological Investigation. 2000 ; 23 258-262.

    Referências citadas na obra
    Richelsen B. Action of growth hormone in adipose tissue. Horm. Res. 1997, 48 (Suppl. 5): 105–110.
    Rosen T., Bengtsson B.A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990, 336: 285–288.
    Boot A.M., Engels M.A.M.J., Boerma G.J.M., Krenning E.P., de Muinck Keizer-Schrama S.M.P.F. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J. Clin. Endocrinol. Metab. 1997, 82: 2423–2428.
    Degerblad M., Elgingy N., Hall K., Sjöberg H.E., Thoren M. Potent effect of recombinant human growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocr. (Copenh) 1992, 126: 387–393.
    Laron Z., Klinger B. Body fat in Laron syndrome patients: effect of insulinlike growth factor I treatment. Horm. Res. 1993, 40: 16–22.
    Guevara-Aguirre J., Rosenbloom A.L., Vasconez O., Martinez V., Gargosky S.E., Allen L., Rosenfeld R.G. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: Comparison of two dosage levels and to GH-treated GH deficiency. J. Clin. Endocrinol. Metab. 1997, 82: 629–633.
    Underwood L.E., Backeljauw P., Duncan V., GHIS Collaborative Group. Effects of insulin-like growth factor I treatment on statural growth, body composition and phenotype of children with growth hormone insensitivity syndrome. Acta Paediatr. Scand. 1999, Suppl. 428: 182–184.
    Kamijo T., Phillips J.A. III Detection of molecular heterogeneity in GH-1 gene deletions by analysis of polymerase chain reaction amplification products. J. Clin. Endocrinol. Metab. 1992, 74: 786–789.
    Arnhold I.J.P., Oliveira S.B., Osorio M.G.F., Mendonca B.B. Insulin-like growth factor-I treatment in two children with growth hormone gene deletions. J. Pediatr. Endocrinol. Metab. 1999, 12: 499–506.
    Boot A.M., Bouquet J., de Ridder M.A.J., Krenning E.P., de Muinck Keizer-Schrama S.M.P.F. Determinants of body composition measured by dualenergy X-ray absorptiometry in Dutch children and adolescents. Am. J. Clin. Nutr. 1997, 66: 232–238.
    Carrilho A.J.F., Medina W.L., Nakandakare E.R., Quintão E.C.R. Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine. Clin. Pharmacol. Ther. 1997, 62: 82–88.
    Osorio M.G.F., Bianco A.C., Estefan V., Segura T.C., Arnhold I.J.P., Nicolau W., Mendonca B.B. Body composition and bone mass of children with hypopituitarism following six months of human growth hormone therapy. Arq. Bras. Endocrinol. Metabol. 1998, 42: 357–362.
    Ranke M.B., Savage M.O., Chatelain P.G., Preece M.A., Rosenfeld R.G., Blum M.F., Wilton P. Insulin-like growth factor I improves height in growth hormone insensitivity: Two years results. Horm. Res. 1995, 44: 253–264.
    Backeljauw P.F., Underwood L.E., GHIS Collaborative Group. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome - A clinical research center study. J. Clin. Endocrinol. Metab. 1996, 81: 3312–3317.
    Klinger B., Laron Z. Three year treatment of children with Laron syndrome. J. Pediatr. Endocrinol. Metab. 1995, 8: 149–158.
    Woods K.A., Camacho-Hübner C., Savage M.O., Clark A.J.L. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New Engl. J. Med. 1996, 335: 1363–1367.
    Heinrichs C., Vis H.L., Bergmann P., Wilton P., Bourguignon J.P. Effects of 17 months treatment using recombinant insulin-like growth factor-I in two children with growth hormone insensitivity (Laron) syndrome. Clin. Endocrinol. 1993, 38: 647–651.
    Rudling M., Olivecrona H., Eggertsen G., Angelin B. Regulation of rat hepatic low density lipoprotein receptors–in vivo stimulation by growth hormone is not mediated by insulin-like growth factor I. J. Clin. Invest. 1996, 97: 292–299.
    Rudling M., Norstedt G., Olivecrona H., Reihnér E., Gustafsson J.-A., Angelin B. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc. Natl. Acad. Sci. USA. 1992, 89: 6983–6987.